Skip to content
  • About
  • Contact
  • Our Staff
  • Advertise
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Decentralized trials

How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development
Posted in
  • Industry Landscape

How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development

In 2024, nearly 85 percent of U.S. clinical trials failed to enroll sufficient participants on schedule, … How Poor Clinical Trial Recruitment Is Quietly Killing Drug DevelopmentRead more

by Jayshree Gondane•February 3, 2026February 3, 2026•0

Recent Posts

  • How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development
  • Why So Many Pharma Companies Get Stuck in Phase I Clinical Trials
  • Designing Content Ecosystems for Specialty Brands
  • Patient Education Pipelines Built With Automation
  • Identifying Hidden HCP Segments With Predictive AI hidden HCP segments

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A